entity

Cgmp

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Cgmp: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

6Connections
0Hypotheses
1Analyses
2Outgoing
4Incoming
0Experiments
1Debates

No AI portrait yet

Outgoing (2)

TargetRelationTypeStr
ALZHEIMER'S DISEASEtreatsdisease0.85
NEURODEGENERATIONtreatsdisease0.85

Incoming (4)

SourceRelationTypeStr
Soluble Guanylyl Cyclaseupregulatesenzyme0.90
22749439induces accumulation ofpaper0.90
PDE10Amodulatesprotein0.90
15220933implicated inpaper0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

Does RGS6 upregulation or D2 autoreceptor modulation prevent neurodegeneration i

neurodegeneration | 2026-04-16 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

While RGS6 deficiency causes Parkinson's-like pathology, whether enhancing RGS6

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

Related Research

Hypotheses and analyses mentioning Cgmp in their description or question text

No additional research found